Larvol Delta - Avacta-Therapeutics-Presents-Compelling-Phase-1a-Data-for-Faridoxorubicin-and-the-preCISION-Platform-at-the-European-Society-of-Medical-Oncology-Annual-Congress

faridoxorubicin (AVA6000) - Avacta

https://www.globenewswire.com/news-release/2025/10/19/3169020/0/en/Avacta-Therapeutics-Presents-Compelling-Phase-1a-Data-for-Faridoxorubicin-and-the-pre-CISION-Platform-at-the-European-Society-of-Medical-Oncology-Annual-Congress.html

Oct 19, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next